Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Adam

Showing results (571-580 of 641) with videos related to

Pageof 65
Sort By:
Frontiers in Pharmacology|October 16, 2023
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Frontiers in Pharmacology|March 28, 2024
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Pathology, Research and Practice|January 6, 2024
The emerging role of miRNAs in myocardial infarction: From molecular signatures to therapeutic targetsOsama A Mohammed, Mushabab Alghamdi, Jaber Alfaifi, et al.
International Journal of Biological Macromolecules|April 27, 2024
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markersOsama A Mohammed, Mushabab Alghamdi, Masoud I E Adam, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo InvestigationsOsama A Mohammed, Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S Alamri, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1123Osama A Mohammed, Mustafa Ahmed Abdel-Reheim, Lobna A Saleh, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel ApproachOsama A Mohammed, Mustafa Ahmed Abdel-Reheim, Lobna A Saleh, et al.
Heliyon|March 21, 2024
The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosisOsama A Mohammed, Ahmed S Doghish, Mohannad Mohammad S Alamri, et al.
Journal of Medicinal Chemistry|August 21, 2007
Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myelomaAndrew R Hudson, Steven L Roach, Robert I Higuchi, et al.
Life Sciences|June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenibAlexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
Pageof 65

Showing results (571-580 of 641) with videos related to

Sort By:
Pageof 65
Frontiers in Pharmacology|October 16, 2023
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Frontiers in Pharmacology|March 28, 2024
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Pathology, Research and Practice|January 6, 2024
The emerging role of miRNAs in myocardial infarction: From molecular signatures to therapeutic targetsOsama A Mohammed, Mushabab Alghamdi, Jaber Alfaifi, et al.
International Journal of Biological Macromolecules|April 27, 2024
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markersOsama A Mohammed, Mushabab Alghamdi, Masoud I E Adam, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo InvestigationsOsama A Mohammed, Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S Alamri, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1123Osama A Mohammed, Mustafa Ahmed Abdel-Reheim, Lobna A Saleh, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel ApproachOsama A Mohammed, Mustafa Ahmed Abdel-Reheim, Lobna A Saleh, et al.
Heliyon|March 21, 2024
The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosisOsama A Mohammed, Ahmed S Doghish, Mohannad Mohammad S Alamri, et al.
Journal of Medicinal Chemistry|August 21, 2007
Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myelomaAndrew R Hudson, Steven L Roach, Robert I Higuchi, et al.
Life Sciences|June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenibAlexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
Pageof 65